Seah H. Lim

Dr. Lim has been a leader in hematology and oncology for over 30 years. He is a practicing physician and Professor of Medicine and has held leadership positions at a number of Universities including Brown University, University of Pittsburgh, and New York Medical College. He has been responsible for strategic development of new clinical and research programs focused on translational innovations, bringing new therapies to market. He has run more than 30 clinical trials and worked with many pharma companies in both investigator-initiated studies and pre-licensing studies, and is experienced in regulatory matters such as IND applications. He has received more than $14 million extramural funding from private corporations and the National Institute of Health. He is currently Section Editor for Journal of Translational Medicine. He has more than 150 publications and four patents credited to him. With his wealth of knowledge in administration, healthcare service delivery, research innovation, translational experience, and program development, he co-founded Biocosm, Inc. with Dr. Mukund Karanjikar.